GlassScriptPhysician profile
Markian Kunasz
NPI 1932190915
$4,288.46
in general payments reported to CMS, 2019-2025
21 companies · $1,140 in 2025
The $1,140 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $293 · 2020: $387 · 2021: $470 · 2022: $997 · 2023: $153 · 2024: $848 · 2025: $1,140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,142.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,141.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $446.70 | 2019-2022 | |
| Abbvie INC. | $367.59 | 2023-2025 | |
| Galderma Laboratories, L.P. | $357.58 | 2019-2025 | |
| Tela Bio, INC. | $349.53 | 2021-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Revance Therapeutics, INC. | $323.68 | 2024-2025 | Daxi, Daxxify |
| Polynovo North America LLC | $284.29 | 2024 | Novosorb Btm |
| Acera Surgical, INC. | $279.86 | 2021-2024 | Restrata Wound Matrix |
| Janssen Pharmaceuticals, INC | $249.97 | 2022 | |
| Heron Therapeutics, INC. | $249.10 | 2025 | Zynrelef |
| Merz North America, INC. | $223.56 | 2023-2025 | |
| Kerecis Limited | $182.07 | 2022 | |
| Integra Lifesciences Corporation | $169.76 | 2020-2025 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Sientra, INC. | $169.25 | 2022 | |
| Mentor Worldwide LLC | $148.59 | 2020-2022 | |
| Next Science LLC | $144.42 | 2025 | Xperience, Blastx |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovation Technologies INC | $123.15 | 2021 | |
| Misonix INC | $121.44 | 2020 | |
| Access Pro Medical, LLC | $49.35 | 2023 | Matriderm |
| Pacira Pharmaceuticals Incorporated | $24.89 | 2025 | Exparel |
| Allergan, INC. | $12.12 | 2022 | |
| Stryker Corporation | $11.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Markian Kunasz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.